Elyse E Lower Selected Research

Sarcoidosis (Schaumann Disease)

1/2022	Echocardiographic estimate of pulmonary artery pressure in sarcoidosis patients - real world data from a multi-national study.
1/2022	Riociguat for Sarcoidosis-Associated Pulmonary Hypertension: Results of a 1-Year Double-Blind, Placebo-Controlled Trial.
2/2021	Biologic and advanced immunomodulating therapeutic options for sarcoidosis: a clinical update.
1/2021	Roflumilast (Daliresp®) to reduce acute pulmonary events in fibrotic sarcoidosis: a multi-center, double blind, placebo controlled, randomized clinical trial.
1/2021	Evaluating the Minimal Clinically Important Difference of the King's Sarcoidosis Questionnaire in a Multicenter Prospective Study.
1/2021	COVID-19 and Sarcoidosis, Readiness for Vaccination: Challenges and Opportunities.
10/2020	Balancing Altered Calcium Metabolism with Bone Health in Sarcoidosis.
9/2020	Use of third-line therapies in advanced sarcoidosis.
1/2020	Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire.
1/2020	Methotrexate in sarcoidosis: hematologic and hepatic toxicity encountered in a large cohort over a six year period.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elyse E Lower Research Topics

Disease

43	Sarcoidosis (Schaumann Disease) 01/2022 - 07/2002
15	Neoplasms (Cancer) 01/2022 - 03/2002
13	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2002
9	Pulmonary Sarcoidosis 03/2020 - 10/2002
7	Fatigue 01/2021 - 05/2008
6	Pulmonary Hypertension 03/2022 - 06/2006
6	Neoplasm Metastasis (Metastasis) 06/2020 - 03/2002
6	Necrosis 03/2020 - 03/2003
4	Chronic Disease (Chronic Diseases) 01/2015 - 05/2008
3	Lung Diseases (Lung Disease) 02/2021 - 03/2004
3	Chilblains (Chilblain) 01/2016 - 07/2002
2	Cough 01/2021 - 10/2002
2	Hypercalcemia (Milk Alkali Syndrome) 10/2020 - 01/2014
2	Infections 09/2020 - 01/2020
2	Neurosarcoidosis 01/2020 - 09/2008
2	Carcinoma (Carcinomatosis) 11/2018 - 03/2002
2	Osteoporosis 01/2014 - 06/2011
2	Granuloma 07/2012 - 06/2011
2	Nausea 11/2009 - 03/2004
2	Dyspnea (Shortness of Breath) 06/2006 - 07/2002
2	Inflammation (Inflammations) 08/2005 - 01/2004
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021
1	Hypercalciuria 10/2020
1	Kidney Calculi (Kidney Stone) 10/2020
1	Hypersensitivity (Allergy) 09/2020
1	COVID-19 01/2020
1	Hyperplasia 11/2018
1	Papilloma (Papillomatosis) 11/2018
1	Noninfiltrating Intraductal Carcinoma (DCIS) 11/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Carcinogenesis 01/2018
1	Fever (Fevers) 01/2018
1	Neutropenia 01/2018
1	Pain (Aches) 01/2018
1	Drug-Related Side Effects and Adverse Reactions 01/2016
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2016
1	Bone Fractures (Bone Fracture) 01/2014
1	Bronchiectasis 12/2013
1	Apnea 02/2013

Drug/Important Bio-Agent (IBA)

10	Infliximab (Remicade)FDA Link 09/2020 - 01/2004
8	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2021 - 10/2002
8	Pharmaceutical PreparationsIBA 09/2020 - 04/2002
7	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 03/2003
5	Estrogen ReceptorsIBA 01/2022 - 03/2005
5	Hormones (Hormone)IBA 01/2017 - 03/2005
5	Prednisone (Sone)FDA LinkGeneric 01/2017 - 10/2002
4	Cytotoxins (Cytolysins)IBA 02/2021 - 02/2010
4	Rituximab (Mabthera)FDA Link 09/2020 - 01/2012
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2013 - 10/2002
3	Biological ProductsIBA 02/2021 - 06/2013
3	Vitamin D FDA LinkGeneric 10/2020 - 06/2011
3	Adrenocorticotropic Hormone (ACTH)FDA Link 09/2020 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 06/2020 - 03/2002
3	GlucocorticoidsIBA 01/2016 - 06/2013
3	Azathioprine (Imuran)FDA LinkGeneric 01/2015 - 09/2008
3	Dexmethylphenidate Hydrochloride FDA LinkGeneric 11/2009 - 05/2008
2	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2020
2	Estrogens (Estrogen)FDA Link 01/2022 - 04/2002
2	Adalimumab (Humira)FDA Link 09/2020 - 06/2013
2	Biomarkers (Surrogate Marker)IBA 06/2020 - 01/2017
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 09/2008
2	AntibodiesIBA 01/2019 - 02/2010
2	Leflunomide (Arava)FDA LinkGeneric 06/2013 - 03/2004
2	CytokinesIBA 07/2012 - 03/2003
2	Methylphenidate (Ritalin)FDA LinkGeneric 07/2012 - 11/2009
2	Monoclonal AntibodiesIBA 08/2010 - 01/2004
2	Tamoxifen FDA LinkGeneric 01/2009 - 04/2002
2	Trastuzumab (Herceptin)FDA Link 01/2009 - 06/2003
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2008 - 03/2006
2	Thalidomide (Thalomid)FDA Link 01/2004 - 07/2002
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 01/2022
1	riociguatIBA 01/2022
1	DEAE-Dextran (Pulsar)IBA 01/2022
1	VaccinesIBA 01/2021
1	RoflumilastIBA 01/2021
1	Prostaglandins AIBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	CalciumIBA 10/2020
1	25-hydroxyvitamin DIBA 10/2020
1	Calcitriol (Calcijex)FDA LinkGeneric 10/2020
1	OsteopontinIBA 11/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Carbon MonoxideIBA 01/2018
1	Naproxen (Naprosyn)FDA LinkGeneric 01/2018
1	SteroidsIBA 01/2018
1	pegfilgrastim (Neulasta)FDA Link 01/2018
1	CateninsIBA 08/2017
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 01/2016
1	CreatinineIBA 01/2016
1	Immunologic Factors (Immunomodulators)IBA 07/2015
1	SolutionsIBA 07/2015
1	PlasticsIBA 07/2015
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 06/2014
1	Bosentan (Tracleer)FDA Link 04/2014

Therapy/Procedure

34	Therapeutics 03/2022 - 04/2002
3	Drug Therapy (Chemotherapy) 01/2018 - 11/2009
1	Biological Therapy 03/2020
1	Premedication 01/2018
1	Isogeneic Transplantation 08/2017
1	Defibrillators (Defibrillator) 01/2017